|Day Low/High||14.42 / 15.17|
|52 Wk Low/High||9.01 / 24.68|
Stocks snap a holding pattern to pull lower on Monday afternoon as a crude oil slump weighS on the energy sector.
Biotech companies show more energy than the rest of the market Monday.
Stocks move mostly higher on Monday morning as a hearing on Russia's involvement in the U.S. election begins on Capitol Hill.
CytomX Therapeutics, Aevi Genomic Medicine and Esperion Therapeutics were among the biotech stock movers in premarket trading on Monday.
Shares of the biotech, which researches cancer drugs, were up nearly 30% ahead of market's open.
Stock futures move mostly lower on Monday after the weekend's G20 meeting raises fears over protectionist attitudes among the world's largest economies.
Teleconference Scheduled for Monday, March 20, 2017 at 8:00 a.m. ET
CTLA-4 Probody Moves to IND-Enabling Studies
Triggers $15 Million Milestone Payment to CytomX
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AER, AIMC, ALLY, BKU, PH, VSH Downgrades: CRAY, HMSY, OPK, SOHO, SONS, TRNC, TSRI, UTSI Initiations: CTMX, DERM Read on to get TheStreet Quant Ratings' detailed report: